EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, T.-C.
Right arrow Articles by Tzang, B.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, T.-C.
Right arrow Articles by Tzang, B.-S.
Experimental Biology and Medicine 232:195-203 (2007)
© 2007 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Beneficial Effects of Treatment with Transglutaminase Inhibitor Cystamine on Macrophage Response in NZB/W F1 Mice

Tsai-Ching Hsu*, Szu-Yi Chiang{dagger}, Chih-Yang Huang{ddagger}, Gregory J. Tsay*,§, Chiao-Wen Yang*, Chien-Ning Huang§ and Bor-Show Tzang||,1

* Institute of Immunology, Chung Shan Medical University, Taichung 40203, Taiwan, R.O.C; {dagger} Department of Health, Executive Yuan, Hua-Lien Hospital, Hua-Lien 97061, Taiwan, R.O.C; {ddagger} Graduate Institute of Chinese Medical Science, China Medical University, Taichung 40402, Taiwan, R.O.C; § Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40203, Taiwan, R.O.C.; || Institutes of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung 40203, Taiwan, R.O.C.

To whom requests for reprints should be addressed at 1 Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung, Taiwan, R.O.C. 110 section 1, Chien Kuo N. Road, Taichung 402, Taiwan, R.O.C. E-mail: bstzang{at}csmu.edu.tw

Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disorder of unknown etiology. However, the definitive mechanisms remain obscure. Recently, transglutaminase 2 (TG2) was implicated in the pathogenesis of SLE. Cystamine, which inactivates TG2 activity by forming a mixed disulfide, may interfere with and inhibit other thiol-dependent enzymes such as caspases. To investigate the effects of cystamine in SLE pathogenesis, this in vivo study assessed the serum and macrophage response after administration of cystamine to NZB/W F1 mice. The experimental results demonstrated for the first time a significant reduction in TG2 and matrix metalloproteinase (MMP)-9 activity; tissue inhibitor of metalloproteinases (TIMP)-1, TIMP-2, TG2, tumor necrosis factor alpha, and tumor growth factor beta mRNA expression; and anticardiolipin autoantibodies (aCL) in NZB/W F1 mice following cystamine administration. It strongly suggests the therapeutic potential of cystamine in SLE.

Key Words: systemic lupus erythematosus (SLE) • matrix metalloproteinase (MMP) • transglutaminase 2 (TG2) • cystamine




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
N. Shweke, N. Boulos, C. Jouanneau, S. Vandermeersch, G. Melino, J.-C. Dussaule, C. Chatziantoniou, P. Ronco, and J.-J. Boffa
Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-{beta} Activation and Cell Infiltration
Am. J. Pathol., September 1, 2008; 173(3): 631 - 642.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Experimental Biology and Medicine.